LATIMER Trademark

Trademark Overview


On Thursday, December 19, 2024, a trademark application was filed for LATIMER with the United States Patent and Trademark Office. The USPTO has given the LATIMER trademark a serial number of 98911924. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, July 10, 2025. This trademark is owned by Latimer Medical LLC. The LATIMER trademark is filed in the Medical Instrument Products category with the following description:

Gloves for medical purposes; Tongue depressors for medical purposes; Elastic compression bandages for medical purposes

General Information


Serial Number98911924
Word MarkLATIMER
Filing DateThursday, December 19, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, July 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesGloves for medical purposes; Tongue depressors for medical purposes; Elastic compression bandages for medical purposes

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, December 19, 2024
Primary Code010
First Use Anywhere DateSaturday, November 2, 2024
First Use In Commerce DateSaturday, November 2, 2024

Trademark Owner History


Party NameLatimer Medical LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSaint Anthony, MN 55418

Trademark Events


Event DateEvent Description
Thursday, December 19, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 5, 2025ASSIGNED TO EXAMINER
Thursday, December 19, 2024NEW APPLICATION ENTERED
Thursday, July 10, 2025NON-FINAL ACTION WRITTEN
Thursday, July 10, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 10, 2025NON-FINAL ACTION E-MAILED